Table 1 Demographic and clinical data of RA patients from cohort 1 stratified by presence or absence of ectopic lymphoid neogenesis (ELN)
Total (n = 63) | ELN+ | ELN– | p value | |
|---|---|---|---|---|
n = 30 (47.6 %) | n = 33 (52.4 %) | |||
Female, n (%) | 41 (65) | 21 (70) | 20 (61) | NS |
Age (years) | 59 (49; 69) | 56 (50; 64) | 62 (49; 70) | NS |
Disease duration (years) | 12.0 (4.8; 17.8) | 9.1 (3.9; 17.8) | 13.1 (10.5; 17.8) | NS |
Tender joint count | 3 (1; 10) | 4 (2; 10) | 2 (1; 10) | NS |
Swollen joint count | 5 (2; 9) | 6 (2; 10) | 3 (1; 8) | NS |
C-reactive protein (mg/dL) | 2.4 (1.1; 4.2) | 2.7 (1.4; 5.1) | 2.1 (0.7; 3.8) | NS |
ESR (mm/h) | 33 (19; 67) | 35 (19; 67) | 31 (18; 53) | NS |
DAS28 | 4.4 (3.3; 5.5) | 5.1 (3.9; 5.7) | 4.0 (3.0; 4.9) | 0.039 |
RF (IU) | 128 (24; 257) | 138 (61; 256) | 74 (17; 325) | NS |
ACPA (IU) | 254 (0; 782) | 257 (0; 701) | 251 (0; 822) | NS |
Number of DMARDs taken before biopsy | 2 (1; 3) | 2 (1; 3) | 2 (1; 4) | NS |
Number (%) of patients taking oral steroidsa | 46 (73) | 23 (76) | 23 (70) | NS |